Skip to main content
EN
CH
Hit enter to search or ESC to close
Close Search
search
Menu
Juvelook & Lenisna
What is PDLLA
Benefits
Juvelook
Lenisna
Before & After
Juvelook
Lenisna
Media
JULIA
Newsletter
Conference
Clinical study
News
FAQ
Contact us
search
News
News
Total 22
Newest
Best
Viewed
Updated
Number
Thumbnail
Title
Date
Notice
[Announcement] Official Letter Confirming VAIM’s Patent Ownership and Technological Independence
|
2025.07.04
2025.07.04
21
VAIM Successfully Hosts the “JUVELOOK TAIWAN MASTER ACADEMY WEBINAR” in Taiwan
|
2025.06.30
2025.06.30
20
VAIM Partner Successfully Hosts ‘JUVELOOK SHINE LENISNA BLOOM Insights and Techniques’ in Malaysia
|
2025.06.24
2025.06.24
19
VAIM Hosts ‘JULIA SUMMIT ASIA’ in Hong Kong, Advancing Academic Dialogue on Juvelook Across the Region
|
2025.05.07
2025.05.07
18
Juvelook Receives Regulatory Approval in Russia; Launch Event in Moscow Highlights Global Expansion Strategy
|
2025.05.02
2025.05.02
17
Juvelook Wins 'Best Injectable of Skin Revitalization' at 2025 AMWC, Gaining Global Recognition
|
2025.04.08
2025.04.08
16
VAIM and VAIM GLOBAL Merge to Strengthen Global Aesthetic Leadership
|
2025.04.01
2025.04.01
15
VAIM GLOBAL Successfully Hosts the ‘2025 JUPITER International Symposium’
|
2025.03.28
2025.03.28
14
Juvetek Leads the Way in Revolutionizing Aesthetic Medicine in Thailand
|
2025.03.27
2025.03.27
13
VAIM GLOBAL Expands Global Presence with Participation in IMCAS 2025
|
2025.02.28
2025.02.28
12
VAIM GLOBAL Unveils New Findings on 'JUVELOOK' for Photoaging and Pigmentation Treatment
|
2025.02.27
2025.02.27
1
2
3
»
Last
All
Title
Content
Author
Search
Powered by KBoard
Contact Us
+82-2-6214-0857
official@vaim.co.kr
Connect
Close Menu
Juvelook & Lenisna
What is PDLLA
Benefits
Juvelook
Lenisna
Before & After
Juvelook
Lenisna
Media
JULIA
Newsletter
Conference
Clinical study
News
FAQ
Contact us
EN
CH